Daré Bioscience(DARE) - 2025 Q4 - Earnings Call Transcript

Daré Bioscience (NasdaqCM:DARE) Q4 2025 Earnings call March 26, 2026 04:30 PM ET Company ParticipantsDouglas Tsao - Managing Director of Equity ResearchLeona Nease - Biotech Equity Research AssociateMarDee Haring-Layton - Chief Accounting OfficerSabrina Martucci Johnson - President and CEOConference Call ParticipantsKemp Dolliver - Director of Research and Senior AnalystOperatorWelcome to the conference call hosted by Daré Bioscience to review the company's 2025 financial results and provide a business upda ...